Joanne M. Donovan, CMO at Edgewise Therapeutics, Inc. (EWTX), sold 28,662 shares at $32.31 ($926K) on 2026-04-01, disclosed to the SEC on 2026-04-02.
Scheduled sale ($926k) by CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EWTX | SELL | 2026-03-31 | $1.4M | — | Filing → |
| EWTX | SELL | 2026-03-30 | $1.0M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $38K | — | Filing → |